𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An In Vivo Microdialysis Study of Striatal 6-[18F]Fluoro-L-m-Tyrosine Metabolism

✍ Scribed by Shaun Jordan; Krzysztof S. Bankiewicz; Jamie L. Eberling; Henry F. VanBrocklin; James P. O'Neil; William J. Jagust

Book ID
110420558
Publisher
Springer
Year
1998
Tongue
English
Weight
472 KB
Volume
23
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A within-subject comparison of 6-[18F]fl
A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease
✍ Catherine L. Gallagher; Bradley T. Christian; James E. Holden; Onofre T. Dejesus πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

## Abstract Progression of Parkinson's disease symptoms is imperfectly correlated with positron emission tomography biomarkers for dopamine biosynthetic pathways. The radiopharmaceutical 6‐[^18^F]fluoro‐m‐tyrosine is not a substrate for catechol‐__O__‐methyltransferase and therefore has a more favo

Localization of trapping of 6-[18F]fluor
Localization of trapping of 6-[18F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET
✍ W. Douglas Brown; Onofre T. DeJesus; Robert W. Pyzalski; Lisamarie Malischke; An πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 488 KB

The purpose of this study was to address four major questions regarding 6-FMT, a noncatecholic PET tracer for AAAD: 1) Where is the specific uptake of 6-FMT? 2) Why does it accumulate where and to the degree that it does? 3) How does its uptake differ from that of fluoroDOPA globally? and 4) Does it